Raj R, Kumar A, Prachi Sood, Kumar R, Rana V. Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer. J. Res. Appl. Sci. Biotechnol. [Internet]. 2023 Jun. 12 [cited 2024 Nov. 5];2(3):55-63. Available from: https://jrasb.com/index.php/jrasb/article/view/232